Wow, I'm really surprised to read such a damning perspective on GLP-1 analogues, more especially so on a diabetes forum. <snip>
Well I reckon it's all about liability. Nobody wants to sit down at the court house on the wrong seat when something goes south and as soon as there's a far out potential for harm use is limited to short time and a gazillion warning stickers are tacked on, just to be on the safe side. Now I'm all for safety but it's approaching cringeworthiness at times. In some cases we're letting people die because potential treatment hasn't undergone another umpteenth studies.The thing that concerned me when I looked into this was that on the NICE pathway (which admittedly tends to be out of date) the use of GLP-1 analogues was well down the treatment pathway and with all kinds of reasons to stop treatment after 3 months.
The up front specification looked good - insulin production up, glucagon production down, protection and possible regeneration of Beta cells - but the more I looked the more caveats I found.
I'm currently trying to work out how to get some expert advice on this.
Probably require a private consultation.
I was listening to a podcast today and the guest posited that the optimal metabolic state in healthy humans is actually insulin down and glucagon up. The notion is that insulin high is dealing with excess exogenous carbohydrate, whereas glucagon up is creating just the right amount of endogenous carbohydrate to makeup the shortfall. Ergo flatline glucose and low insulin = optimal.
Obviously there are nuances (and many other factors) at play, particularly in those who are already metabolically broken, but nonetheless it seems logical that this should be the target for optimal homeostasis. Instead of cranking up the insulin in order to deal with excess carbohydrate, glucagon is ensuring a steady drip feed from the liver.
EDIT: I think it was Ben Bikman on the Low carb MD Podcast #58 (the guy is no fool)
My emphasis.Glucagon is a peptide hormone, produced by alpha cells of the pancreas. It works to raise the concentration of glucose and fatty acids in the bloodstream, and is considered to be the main catabolic hormone of the body.[3] It is also used as a medication to treat a number of health conditions. Its effect is opposite to that of insulin, which lowers the extracellular glucose.[4] It is produced from proglucagon, encoded by the GCG gene.
The pancreas releases glucagon when the concentration of insulin (and indirectly glucose) in the bloodstream falls too low. Glucagon causes the liver to convert stored glycogen into glucose, which is released into the bloodstream.[5] High blood-glucose levels, on the other hand, stimulate the release of insulin. Insulin allows glucose to be taken up and used by insulin-dependent tissues. Thus, glucagon and insulin are part of a feedback system that keeps blood glucose levels stable. Glucagon increases energy expenditure and is elevated under conditions of stress.[6] Glucagon belongs to the secretin family of hormones.
Hi there,If your control is broken, then the usual rules may not apply (as you noted).
My specific issue is extended dawn phenomenon, where BG keeps on rising until about noon, then drops sharply to normal. Eating/not eating, exercise/not exercise doesn't seem to make much difference.
One explanation is over production of glucagon.
Hmm...checking Wikipedia as I write this and wondering.
https://en.wikipedia.org/wiki/Glucagon
My emphasis.
The bit that just confused me is "The pancreas releases glucagon when the concentration of insulin (and indirectly glucose) in the bloodstream falls too low. "
I thought that it was released when BG was low and insulin was high. That extract doesn't seem to make sense.
Unless glucagon does not suppress insulin production at all (which I thought it did, but can't find in the Wikipedia article).
So, if it is independent, then insulin production falls as BG falls and both drop together.
When BG falls too far then glucagon is released to push glucose (amongst other things) out of the liver and get BG to rise.
When BG rises then insulin production is stimulated.
I assume that rising BG also suppresses glucagon production.
So I'm now reviewing what I thought I understood.
Are insulin and glucagon completely independent, and the common factor in their production is stimulation by BG levels?
Either way, it looks as though my problem may be too much glucagon causing glycogenolysis (release of glucose from the liver) and gluconeogenesis (production of glucose from protein/fats).
I assume that if my BG is up, then the release of further glucose into the bloodstream is a mistake.
If that is combined with the slow initial release of insulin then this could perhaps explain extended DP.
{retires holding head in hands}
@LittleGreyCat - could you update on what you did since last year ?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?